Erythrodermie mit Brentuximab-Vedotin (Hautnebenwirkungen bei Mycosis fungoides)

J Dtsch Dermatol Ges. 2021 Jan;19(1):99-102. doi: 10.1111/ddg.14197_g.

[Article in German]

Authors

Alessandro Pileri¹, Alba Guglielmo¹, Annalisa Patrizi¹, Beatrice Casadei², Clara Bertuzzi³, Pier Luigi Zinzani², Claudio Agostinelli³

Affiliations

¹ Dermatology Unit, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy.
² Hematology Unit, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
³ Hematopathology Unit, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

PMID: 33491897
DOI: 10.1111/ddg.14197_g

No abstract available

Publication types

Letter